Teton Advisors’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-26,000
Closed -$371K 475
2019
Q1
$371K Sell
26,000
-2,160
-8% -$29.7K 0.04% 363
2018
Q4
$322K Sell
28,160
-618
-2% -$9.54K 0.04% 370
2018
Q3
$576K Sell
28,778
-14,432
-33% -$314K 0.05% 313
2018
Q2
$1.08M Sell
43,210
-3,136
-7% -$75.4K 0.1% 226
2018
Q1
$1.19M Hold
46,346
0.11% 212
2017
Q4
$1.18M Hold
46,346
0.11% 209
2017
Q3
$1.3M Hold
46,346
0.12% 189
2017
Q2
$1.39M Buy
46,346
+160
+0.3% +$4.53K 0.14% 181
2017
Q1
$1.38M Buy
46,186
+18,186
+65% +$569K 0.14% 185
2016
Q4
$969K Buy
28,000
+4,000
+17% +$138K 0.1% 231
2016
Q3
$1.59M Sell
24,000
-3,400
-12% -$212K 0.14% 219
2016
Q2
$1.55M Hold
27,400
0.14% 220
2016
Q1
$1.6M Hold
27,400
0.15% 211
2015
Q4
$1.61M Hold
27,400
0.14% 219
2015
Q3
$1.57M Hold
27,400
0.12% 238
2015
Q2
$2.47M Hold
27,400
0.17% 204
2015
Q1
$2.64M Hold
27,400
0.18% 190
2014
Q4
$2.4M Hold
27,400
0.16% 204
2014
Q3
$2.5M Buy
27,400
+2,800
+11% +$303K 0.18% 189
2014
Q2
$2.83M Hold
24,600
0.19% 181
2014
Q1
$2.98M Sell
24,600
-200
-0.8% -$26.2K 0.2% 166
2013
Q4
$3.12M Sell
24,800
-200
-0.8% -$24K 0.22% 157
2013
Q3
$2.72M Hold
25,000
0.21% 158
2013
Q2
$2.11M Buy
+25,000
New +$2.07M 0.18% 173

Other funds holding TRIB

Teton Advisors's TRIB Position: Q2 2019 in Review

Teton Advisors sold out of Trinity Biotech (TRIB) in Q2 2019, closing a stake of 26,000 shares — an estimated $371K sold.

Teton Advisors first reported a position in TRIB in Q2 2013 and held it in 24 quarters. The position peaked at $3.12M in Q4 2013. 35 funds tracked by Wall St. Rank hold TRIB as of Q2 2019.

  • Teton Advisors reported no remaining Trinity Biotech position as of Q2 2019 after selling out during the quarter.
  • Teton Advisors sold 26,000 Trinity Biotech shares in Q2 2019, an estimated $371K.
  • Teton Advisors first reported a position in Trinity Biotech in Q2 2013 and held it in 24 quarters.
  • Teton Advisors's Trinity Biotech position peaked at $3.12M in Q4 2013.
  • 35 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2019.

Based on Teton Advisors's 13F filing for Q2 2019, filed 2 Aug 2019.